ADA Virtual Meeting June 2020 - Poster

Many Benefits of Empagliflozin Persist in Those with Reduced Renal Function: Updated Data from the Association of British Clinical Diabetologists (ABCD) Audit Programme

Thomas SJ Crabtree, Karen Adamson, Alex Bickerton, Suzanne M Phillips, Alison Evans, Anthony Robinson, Marc Atkin, David S Morris, David M Williams, Jeffrey W Stephens, Devesh K Sennik, Anurita Rohilla, Melissa L Cull, Rajeev P Raghavan, Mahender Yadagiri, Ian W Gallen, Robert EJ Ryder

Discipline

Diabetes
Resource taxonomy
Audit Posters
Clinical taxonomy
Chronic kidney disease Diabetic nephropathy Treatments for diabetes Type 2 diabetes mellitus
Listing status
Current

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL
  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE  Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE . ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd